Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells.
about
Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia.Quenching the quorum sensing system: potential antibacterial drug targets.Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Pseudomonas aeruginosa Homoserine lactone activates store-operated cAMP and cystic fibrosis transmembrane regulator-dependent Cl- secretion by human airway epitheliaThe quorum sensing volatile molecule 2-amino acetophenon modulates host immune responses in a manner that promotes life with unwanted guests.Regional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin.The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiotaClarithromycin delays progression of bronchial epithelial cells from G1 phase to S phase and delays cell growth via extracellular signal-regulated protein kinase suppressionPathogen- and host-directed anti-inflammatory activities of macrolide antibioticsAzithromycin and lower respiratory tract infections.Macrolide immunomodulatory effects and symptom resolution in acute exacerbation of chronic bronchitis and acute maxillary sinusitis: a focus on clarithromycin.Treatment of Pseudomonas aeruginosa infection in critically ill patients.Peroxisome proliferator-activated receptors mediate host cell proinflammatory responses to Pseudomonas aeruginosa autoinducer.A European perspective on topical ophthalmic antibiotics: current and evolving options.Paraoxonase 2 modulates a proapoptotic function in LS174T cells in response to quorum sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone.Bench-to-bedside review: Quorum sensing and the role of cell-to-cell communication during invasive bacterial infection.Role of PON2 in innate immune response in an acute infection model.The differential effects of azithromycin on the airway epithelium in vitro and in vivo.Role of macrolide therapy in chronic obstructive pulmonary disease.Targeting mucus hypersecretion: new therapeutic opportunities for COPD?Immunomodulatory effect of linezolid on methicillin-resistant Staphylococcus aureus supernatant-induced MUC5AC overexpression in human airway epithelial cells.Macrolides inhibit Fusobacterium nucleatum-induced MUC5AC production in human airway epithelial cells.Azithromycin inhibits mucus hypersecretion from airway epithelial cells.N-acyl-homoserine lactone confers resistance toward biotrophic and hemibiotrophic pathogens via altered activation of AtMPK6.Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin.Azithromycin use in patients with cystic fibrosis.Clarithromycin Suppresses Chloride Channel Accessory 1 and Inhibits Interleukin-13-Induced Goblet Cell Hyperplasia in Human Bronchial Epithelial CellsClarithromycin inhibits interleukin-13-induced goblet cell hyperplasia in human airway cells.Zinc Deficiency via a Splice Switch in Zinc Importer ZIP2/SLC39A2 Causes Cystic Fibrosis-Associated MUC5AC Hypersecretion in Airway Epithelial Cells.Diesel exhaust particulates affect cell signaling, mucin profiles, and apoptosis in trachea explants of Balb/C mice.Erythromycin attenuates MUC5AC synthesis and secretion in cultured human tracheal cells infected with RV14
P2860
Q33463373-378A201A-1372-4313-B845-728698D9CEDFQ33805168-035DAE72-B967-409C-A1D5-93F3810D9EAEQ33983140-78DB59B0-F672-4371-A3E8-6492B7A3973AQ34251347-576BF5AC-786F-4C7F-AA2E-3DC56FA3D887Q34481845-131D3F36-7566-41DD-877E-D3C525259E4BQ34533624-3C9FC5E5-750E-41D0-911C-9CA0FE25D3BEQ34647328-209935D5-DB60-4986-82AC-4D4CA897A567Q34648711-A57C1E4F-3D0F-4379-AC4D-CCDA99317644Q36072425-94B6DB08-63AB-498E-8599-1BCAF8984487Q36283753-5E924438-92A0-4E4D-A8B3-336C92CC6329Q36505493-6C1C8FDF-77AA-4A2D-A831-07BBC00E5A13Q36607415-D3772A14-CC24-4188-A5F4-F56846CDC1CEQ36747305-863D32F2-2349-481C-9688-3AF7B7638FDDQ36867161-95E8048B-AD14-42CF-B802-A3371FB177EFQ37057316-87F0ED2C-8883-40A8-B38B-A3925F2E6162Q37106083-864A38CF-0481-4CD1-A8F3-3C5473AAB46AQ37238748-FAE89470-A10C-4570-8BF9-2AE51ACAE88FQ37286810-5014340F-7D2C-4B27-A8B4-481394A9FD88Q37319950-74BBA02C-3E9B-4729-8DE8-FEA5F3EA4AB1Q38217069-32642419-5346-4C0F-85CD-64EC08B2F26BQ38995787-03015130-ABB3-41C4-88DF-62CA20B42144Q39199728-AFD28420-5F2C-4CD4-B70E-3B77D71E0F75Q39350133-289EAF45-0C8F-4B2D-A5CC-74C3068AB1CDQ39704885-8B4A7BFC-3328-4019-8136-472776F16CBDQ39927792-A90F74A5-6C36-471D-958D-D171849FC42FQ41428470-A0C8BE51-F2FD-489B-8CEC-FBFB90BC2A09Q41537548-0EF4BCC7-CBE4-4008-AC8D-FC1459B88C9FQ44966446-45BCE239-A10B-4576-9C2C-A4F59EEEE5EEQ47208524-DF6C5171-1544-4415-97E3-25B6D0CF9C98Q50427124-F8DF4DCA-2738-4545-83A2-0E80B190FB8BQ57705949-621841E3-8188-4067-BD99-5B8A751ACEFD
P2860
Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Azithromycin inhibits MUC5AC p ...... onas aeruginosa autoinducer N-
@nl
Azithromycin inhibits MUC5AC p ...... ine lactone in NCI-H292 Cells.
@en
type
label
Azithromycin inhibits MUC5AC p ...... onas aeruginosa autoinducer N-
@nl
Azithromycin inhibits MUC5AC p ...... ine lactone in NCI-H292 Cells.
@en
prefLabel
Azithromycin inhibits MUC5AC p ...... onas aeruginosa autoinducer N-
@nl
Azithromycin inhibits MUC5AC p ...... ine lactone in NCI-H292 Cells.
@en
P2093
P2860
P921
P1476
Azithromycin inhibits MUC5AC p ...... ine lactone in NCI-H292 Cells.
@en
P2093
Hideaki Ohno
Jun-ichi Kadota
Katsunori Yanagihara
Kazuhiro Tsukamoto
Kazunori Tomono
Masafumi Seki
Shigeru Kohno
Yasuhito Higashiyama
Yohei Mizuta
Yoichi Hirakata
P2860
P304
P356
10.1128/AAC.48.9.3457-3461.2004
P407
P577
2004-09-01T00:00:00Z